The global surgical gloves market is expected to flourish strongly through 2032 owing to the soaring awareness about contagious diseases and cross-contamination in developing countries.

Growing incidences of chronic diseases, an increase in the world’s senior population, as well as greater public awareness of the need to stop the spread of infections are a few key drivers that are expected to fuel industry growth. For instance, in March 2022, Supermax Corporation Berhad announced plans to extend its geographic reach and establish a manufacturing facility in Texas in the United States. This tactical choice aided the organization in enhancing its geographical presence and expanding its clientele.

The surgical gloves industry has been divided in terms of product, form, usage, sterility, distribution channel, end-use, and region.

Based on product, the neoprene gloves segment is anticipated to amass revenues of more than $383 million by 2032. These gloves have excellent finger dexterity, exceptional pliability, impact resistance, and great cut and tear resistance, which is further expected to contribute to segmental growth.

With respect to usage, the reusable gloves segment was valued at $499 million in 2022. Multiple clinical benefits provided by reusable gloves in the long haul are expected to foster market expansion through the review timeline.

In terms of sterility, the sterile gloves segment held more than $2 billion in 2022. The segment is poised to grow positively over the forecast years credited to the decreased risk of contamination and protection provided by sterile gloves.

Based on distribution channel, the brick and mortar segment is speculated to garner high gains over the forthcoming years attributed to the greater accessibility and a broad network of physical stores. For consumables like medical gloves, the accessibility, appeal, and acceptance of brick-and-mortar retailers are continually increasing.

Under end-use, the hospitals segment held 44% market share in 2022. The segment is projected to foster exponential growth through the research period fueled by the increased use of surgical gloves in hospital settings as well as the rising risk of hospital-acquired infections (HAIs), including surgical site infection and bloodstream infection among others.

From the regional perspective, the North America surgical gloves market was valued at $784 million in 2022. The presence of various surgical glove manufacturers and an increase in operations are two main causes that are anticipated to boost the regional market share. In the US, the number of surgical procedures has been steadily increasing which is likely to propel regional growth over the analysis timeframe.